Meeting Details
Board meeting scheduled for Saturday, May 30, 2026
Agenda Items
- Approval of Audited Standalone Financial Results for Fourth quarter (Q4) and year ended March 31, 2026 along with Audited Report
- Consideration/approval of fundraising through issue of equity shares, convertible securities and/or any other eligible securities
- Fundraising may be conducted via rights issue, preferential basis, or any other permissible mode or combination thereof
- Fundraising subject to regulatory/statutory approvals including shareholder approval
- Appointment of Chief Financial Officer of the Company
- Any other business as deemed fit by the Board with permission of chairperson and majority of directors
Trading Window Status
Trading window closure was previously intimated via letter no. WHL/BSE/TWC-Q4/MARCH/2025-26 dated March 25, 2026
Closure period: From Wednesday, April 1, 2026 until completion of 48 hours after declaration/publication of Unaudited Standalone Financial Results for Q4 ended March 31, 2026
Revised closure end date: Monday, June 1, 2026